These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 13282525)
81. [Electrolytic composition of human gastric juice and its modifications under the action of sympathicotropic and parasympathicotropic substances; considerations on the mechanism of secretion of HCI and its factors of regulation of gastric acidity]. SANGIORGI M; CORSI V Rev Bras Gastroenterol; 1956; 8(1):7-30. PubMed ID: 13323417 [No Abstract] [Full Text] [Related]
82. [Experimental study of a new antacid and anti-ulcer preparation]. MILANI C; TIRONE P; BERTI F Clin Ter; 1961 Jul; 21():58-77. PubMed ID: 13770582 [No Abstract] [Full Text] [Related]
83. [Optimal use of acid-inhibitors in acid-related diseases. Physiological and physiopathological considerations with implications on therapeutic choice]. Waldum HL Tidsskr Nor Laegeforen; 1993 Feb; 113(4):465-9. PubMed ID: 8465291 [TBL] [Abstract][Full Text] [Related]
84. [Action of a methonium compound with 5 C on gastric secretion]. MAGGI AL; MEEROFF M Sem Med; 1952 Jul; 101(3):82-8. PubMed ID: 12995051 [No Abstract] [Full Text] [Related]
86. Antacids in the treatment of gastroduodenal ulcer. Berstad A; Weberg R Scand J Gastroenterol; 1986 May; 21(4):385-91. PubMed ID: 3523739 [No Abstract] [Full Text] [Related]
87. [Drugs inhibiting and inactivating gastric secretion. (Current status)]. Stroescu V Med Interna (Bucur); 1965 Sep; 17(9):1119-22. PubMed ID: 5845678 [No Abstract] [Full Text] [Related]
88. [Medical treatment of peptic ulcer]. Meeroff JC; Meeroff M Rev Esp Enferm Apar Dig; 1977 Feb; 49(2):251-84. PubMed ID: 319516 [No Abstract] [Full Text] [Related]
89. The role of acid in upper gastrointestinal haemorrhage due to ulcer and stress-related mucosal damage. Peterson WL Aliment Pharmacol Ther; 1995; 9 Suppl 1():43-6. PubMed ID: 7495942 [TBL] [Abstract][Full Text] [Related]
91. In vivo and in vitro evaluation of liquid antacids. Fordtran JS; Morawski SG; Richardson CT N Engl J Med; 1973 May; 288(18):923-8. PubMed ID: 4693244 [No Abstract] [Full Text] [Related]
92. Inhibition of gastric peptic activity by antacids and pepstatin. Holm HA; Berstad A Scand J Gastroenterol Suppl; 1976; 42():119-21. PubMed ID: 13483 [No Abstract] [Full Text] [Related]
93. [Use of aluminum glycyrrhizate in gastric pathology and especially in gastroduodenal ulcer]. MONGES H; LEGRE M Sem Hop Ther Paris; 1961 Dec; 37():950-3. PubMed ID: 14475381 [No Abstract] [Full Text] [Related]
94. [Testing of acid-binding and secretion-inhibiting substances with the aid of intragastric pH-measurement]. KINZLMEIER H; HENNING N; DEMLING L Klin Wochenschr; 1954 Jan; 32(1-2):40-5. PubMed ID: 13143680 [No Abstract] [Full Text] [Related]
96. The limitations of current therapy in peptic ulcer disease. Salena BJ; Hunt RH Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747 [TBL] [Abstract][Full Text] [Related]
97. Suppression of gastric hydrochloric acid secretion by enzyme inhibitors; a new approach in research on the therapy of peptic ulcer. HOLLANDER F; JANOWITZ HD AMA Arch Intern Med; 1956 Feb; 97(2):194-200. PubMed ID: 13282525 [No Abstract] [Full Text] [Related]
98. Effect of carbonic anhydrase inhibitors and antacids on the development of gastrointestinal ulcers during treatment with depot-histamine; a preliminary report. HARRISSON JW; PACKMAN EW; GUTH PS; BACK N; CHERNICK WS J Am Pharm Assoc Am Pharm Assoc; 1955 Feb; 44(2):123-5. PubMed ID: 14353732 [No Abstract] [Full Text] [Related]